Picture of BELLUS Health logo

BLU BELLUS Health News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid Cap

Bellus Health Inc Expected To Post A Loss Of 18 Cents A Share: Earnings Preview

* BELLUS Health Inc  BLU.TO   is expected to show a fall in
quarterly revenue when it reports  results on March 6
(estimated). 
    * The Laval Quebec-based  company is expected to report  a
8.2% decrease in revenue to $3.67 thousand from $4 thousand a
year ago, according to the mean estimate from 3 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for BELLUS Health Inc
is for
a loss of 18 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for BELLUS
Health Inc
is C$22​, above​ its last closing price of C$10.30. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.15       -0.16      -0.20     Missed  -21.2
 Jun. 30 2022  -0.16       -0.17      -0.18     Missed  -2.9
 Mar. 31 2022  -0.18       -0.20      -0.13     Beat    35​
 Dec. 31 2021  -0.23       -0.22      -0.18     Beat    17.5
 ​​Sep.        -0.22       -0.21      -0.29     Missed  -36.5
 30 2021                                                
 Jun. 30 2021  -0.20       -0.20      -0.23     Missed  -12.2​
 Mar. 31 2021  -0.11       -0.11      -0.20     Missed  -73.9
 Dec. 31 2020  -0.11       -0.10      -0.10     Met     3.8
 This summary was machine generated March 3 at 11:10 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on BELLUS Health

See all news